These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 39406840
1. Pan-cancer and single-cell analysis reveal dual roles of lymphocyte activation gene-3 (LAG3) in cancer immunity and prognosis. Wang Y, Zhao Y, Zhang G, Lin Y, Fan C, Wei H, Chen S, Guan L, Liu K, Yu S, Fu L, Zhang J, Yuan Y, He J, Cai H. Sci Rep; 2024 Oct 15; 14(1):24203. PubMed ID: 39406840 [Abstract] [Full Text] [Related]
2. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures. Zhang X, Wang Y, A G, Qu C, Chen J. Front Immunol; 2021 Oct 15; 12():721030. PubMed ID: 34531868 [Abstract] [Full Text] [Related]
3. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N, Zhu L, Wang L, Shen Z, Huang X. Comput Struct Biotechnol J; 2022 Oct 15; 20():3106-3119. PubMed ID: 35782736 [Abstract] [Full Text] [Related]
4. Comprehensive analysis of zinc and ring finger 3 in prognostic value and pan-cancer immunity. Liu M, Zhao H, Peng S, Wu Y, Liu Y, Sun W, Zen K, Sun X. FASEB J; 2024 Mar 15; 38(5):e23523. PubMed ID: 38457275 [Abstract] [Full Text] [Related]
10. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis. Gao ZW, Yang L, Liu C, Wang X, Guo WT, Zhang HZ, Dong K. Front Immunol; 2022 Mar 15; 13():903461. PubMed ID: 35663977 [Abstract] [Full Text] [Related]
11. A comprehensive pan-cancer analysis of the expression characteristics, prognostic value, and immune characteristics of TOP1MT. Fei L, Lu Z, Xu Y, Hou G. Front Genet; 2022 Mar 15; 13():920897. PubMed ID: 36035140 [Abstract] [Full Text] [Related]
12. Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA. Ye B, Shi J, Kang H, Oyebamiji O, Hill D, Yu H, Ness S, Ye F, Ping J, He J, Edwards J, Zhao YY, Guo Y. RNA Biol; 2020 Nov 15; 17(11):1666-1673. PubMed ID: 31607216 [Abstract] [Full Text] [Related]
14. CCND1 as a Prognostic and Diagnostic Biomarker and the Impact of Its Epigenetic Alterations on Cancer Survival. Taha MY, Mohamed NO, Alhaj LG, Altayeb I, Basheer A, Idrees S, Said AM, Alfaki M. Cureus; 2024 Jul 15; 16(7):e65504. PubMed ID: 39188436 [Abstract] [Full Text] [Related]
18. Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts. Zeng Z, Gao Y, Li J, Zhang G, Sun S, Wu Q, Gong Y, Xie C. Comput Struct Biotechnol J; 2022 Jul 15; 20():496-507. PubMed ID: 35070171 [Abstract] [Full Text] [Related]
19. PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer. Li L, Feng Q, Wang X. Comput Struct Biotechnol J; 2020 Jul 15; 18():668-675. PubMed ID: 32257050 [Abstract] [Full Text] [Related]
20. Comprehensive analysis of the novel omicron receptor AXL in cancers. Zhang WN, Li XP, Wang PF, Zhu L, Xiao XH, Dai YJ. Comput Struct Biotechnol J; 2022 Jul 15; 20():3304-3312. PubMed ID: 35782741 [Abstract] [Full Text] [Related] Page: [Next] [New Search]